Pregnancy After Cancer Treatment

"Can I get pregnant?" and "Is it safe for me to get pregnant?" are different questions. They have different tests, different answers, and usually different doctors. Pulling them apart makes every later conversation shorter.

The first question is about egg supply, the uterus, and the sperm side if there is one. The second is about recurrence risk, heart function, any hormone medicine you are still taking, and how long your oncologist wants you clear of treatment first.

The National Cancer Institute names four exposures that put ovaries at risk.

Alkylating agents are the chemotherapy class of greatest concern. These drugs work by damaging DNA in dividing cells. NCI states they carry a high risk to fertility because they can stop the ovaries from developing mature eggs and from making estrogen.

Radiation to the pelvis can damage the ovaries directly or destroy eggs. Radiation to the brain is a separate problem. It can disrupt the hormone signals that tell the ovaries to release an egg, even when the ovaries themselves are intact.

A stem cell transplant combines high-dose chemotherapy and often radiation. NCI says it can cause lasting infertility or primary ovarian insufficiency.

Primary ovarian insufficiency, or POI, means the ovaries stop working early. Signs include hot flashes, irregular or absent periods, mood changes, and vaginal dryness. Over the long run, POI also raises the risk of weak bones and heart disease, which is why it is treated as a health issue and not only a fertility issue.

One blood test comes up constantly here. Anti-Mullerian hormone, or AMH, is made by small follicles in the ovary. MedlinePlus describes two uses. One is to estimate how many eggs remain. The other is to predict the response to fertility drugs before in vitro fertilization, or IVF. Know its limit before you read too much into a number: AMH cannot tell you about egg quality and cannot predict whether you will get pregnant. It counts, it does not judge.

Egg supply is only half of it. NCI notes that radiation near the uterus can reduce blood flow or cause scarring. The result may be infertility, or a higher rate of pregnancy complications in a uterus that does conceive.

Surgery on the cervix matters too. The American Cancer Society notes that removing part or all of the cervix raises the risk of miscarriage and early birth. The cervix normally holds the pregnancy in place.

So ask the question directly: is my uterus expected to carry a pregnancy to term? That is not the same as asking whether you still make eggs. A survivor can have a healthy egg supply and a uterus that cannot safely carry, or the reverse.

There are two clocks, and people mix them up.

The first is short. The American Cancer Society notes that some clinicians advise a wait of at least 6 months after chemotherapy ends. That lets eggs exposed to the drugs cycle out.

The second is long. When recurrence risk is highest in the first years, some teams advise waiting 2 to 5 years. After breast cancer, a 2-year wait is sometimes suggested, because hormones that rise in pregnancy might feed hormone-sensitive cells.

Ask which clock applies to you and why. The 6-month clock is about egg damage. The multi-year clock is about your cancer. As a general matter, ACS states that pregnancy does not appear to raise the chance that cancer comes back.

After hormone receptor-positive breast cancer, endocrine therapy usually runs 5 years or more. Those are the same years many people want to have children. The POSITIVE trial tested pausing it.

The design was specific. It enrolled 518 women under 43 with early-stage hormone receptor-positive breast cancer across four continents. Each had already taken at least 18 months of endocrine therapy. They then paused it for up to 2 years to try to conceive, with the plan to restart.

Among 497 women followed, 74 percent had at least one pregnancy and 63.8 percent had at least one live birth. Three hundred sixty-five babies were born. About 9 percent had a recurrence by 3 years. NCI describes that as nearly identical to a similar group of premenopausal women who did not pause.

Read that as evidence about a planned, temporary, monitored pause after 18 months of treatment. It is not evidence about stopping endocrine therapy for good, and it does not cover people outside those entry criteria.

This is the part that gets skipped. NCI lists congestive heart failure and coronary artery disease as late effects of certain cancer drugs and of radiation to the chest. ACS notes that some chemotherapy damages heart cells and weakens the heart, and that chest or abdominal radiation compounds it.

Pregnancy increases the work the heart must do. One NCI-reported study followed childhood cancer survivors. They had about twice the rate of heart problems and severe birth complications. The comparison group was women with no cancer history.

Thyroid function belongs on the same list. NCI notes that radiation to the head and neck can damage the thyroid and cause it to become underactive, and thyroid hormone matters in pregnancy.

Before you start trying, ask whether you need heart imaging and thyroid blood tests first, based on the exact drugs and radiation fields in your record.

The reassuring findings are real and worth stating plainly.

In that same survivor study, birth defect rates did not differ. Babies born to survivors matched babies born to the comparison group. Preterm birth was modestly more common: about 9 percent of survivors' babies arrived before week 37, compared with about 6 percent in the comparison group.

ACS states that children of cancer survivors do not generally face a higher cancer risk. The exception is an inherited cancer syndrome. If your family history or your own diagnosis points that way, get genetic counseling. Do it before pregnancy, not after.

NICHD defines infertility as no pregnancy after 1 year of regular unprotected sex, or after 6 months if the woman is older than 35.

Do not wait out that full window if any of the following are in your treatment record:

• alkylating chemotherapy
• radiation to the pelvis or abdomen
• radiation to the brain
• a stem cell transplant
• periods that never returned after treatment ended

In those cases, ask for a fertility doctor as soon as you start thinking about it. Do not wait out a year of trying. Bring your treatment summary, which should list every drug, the cumulative dose of each, and the radiation fields and doses. Those numbers are what a fertility specialist uses.

• https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-women
• https://www.cancer.gov/about-cancer/coping/survivorship/late-effects
• https://www.cancer.gov/news-events/cancer-currents-blog/2023/pausing-breast-cancer-treatment-to-conceive
• https://www.cancer.gov/news-events/cancer-currents-blog/2022/childhood-cancer-survivors-pregnancy-baby-health
• https://medlineplus.gov/lab-tests/anti-mullerian-hormone-test/
• https://www.nichd.nih.gov/health/topics/infertility/conditioninfo
• https://www.cancer.org/cancer/managing-cancer/side-effects/fertility/pregnancy-after-cancer.html